Ono Pharmaceutical CoMEX:4528N 88 Interest Coverage is 3.48 as of Mar. 2026, which is 98% below its 10-year median of 216.76. GuruFocus rates MEX:4528N with a GF Score™ of 88/100 and a GF Value™ of MXN324.16. The stock has 2 warning signs investors should review. Among 684 Drug Manufacturers companies, Ono Pharmaceutical Co ranks better than 62.72% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Ono Pharmaceutical Co's
Operating Income
for the
three
months ended in Mar. 2026 was MXN448 Mil. Ono Pharmaceutical Co's Interest Expense for the
three
months ended in Mar. 2026 was MXN-129 Mil.
Ono Pharmaceutical Co's interest coverage for the quarter that ended in Mar. 2026 was 3.48.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Ono Pharmaceutical Co's Interest Coverage or its related term are showing as below:
MEX:4528N'
s Interest Coverage Range Over the Past 10 Years
Min: 11.24 Med: 216.76 Max: 1685.69
Current: 26.06
MEX:4528N's Interest Coverage is ranked better than 62.72% of 684
companies
in the Drug Manufacturers industry
Industry Median: 12.765
vs MEX:4528N: 26.06
Ono Pharmaceutical Co (MEX:4528N) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Ono Pharmaceutical Co Interest Coverage Related Terms
Ono Pharmaceutical Co Interest Coverage Historical Data
* Premium members only.
The historical data trend for Ono Pharmaceutical Co's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
MEX:4528N vs LLY, JNJ, ABBV: Interest Coverage Comparison
For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ono Pharmaceutical Co Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Ono Pharmaceutical Co's Interest Coverage falls into.
Ono Pharmaceutical Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ono Pharmaceutical Co (MEX:4528N) has a Interest Coverage of 3.48 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Ono Pharmaceutical Co and its competitors. This is 98% below median its historical median of 216.76. Over the past decade, Ono Pharmaceutical Co's Interest Coverage has ranged from 11.24 to 1,685.69. According to the industry distribution chart, Ono Pharmaceutical Co ranks #255 out of 684 companies in the Drug Manufacturers industry, placing it in the top 37.3%.
Is Ono Pharmaceutical Co's Interest Coverage too high?
Ono Pharmaceutical Co's current Interest Coverage of 3.48 is 98% below median its 10-year median of 216.76. Over the past 10 years, this metric has ranged from a low of 11.24 to a high of 1,685.69. The Drug Manufacturers industry median Interest Coverage is 12.77. Ono Pharmaceutical Co's value of 3.48 is 72.7% below this industry median. Based on the distribution chart, Ono Pharmaceutical Co ranks #255 out of 684 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Ono Pharmaceutical Co has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Ono Pharmaceutical Co's Interest Coverage compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Ono Pharmaceutical Co ranks #255 out of 684 companies for Interest Coverage. This puts Ono Pharmaceutical Co in the upper half of its industry. The industry median Interest Coverage is 12.77. Ono Pharmaceutical Co's value of 3.48 is 72.7% below this benchmark. Historically, Ono Pharmaceutical Co's own Interest Coverage has ranged from 11.24 to 1,685.69 over the past decade. While the company's 10-year median is 216.76 vs. the industry median of 12.77, Ono Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.77, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ono Pharmaceutical Co's current Interest Coverage of 3.48 is 72.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Ono Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ono Pharmaceutical Co's current Interest Coverage is 3.48, which is 98% below median its own 10-year median of 216.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ono Pharmaceutical Co stock overvalued right now?
Ono Pharmaceutical Co (MEX:4528N) has a current Interest Coverage of 3.48. The stock's GF Value™ is MXN324.16, compared to a current price of MXN341.69 — trading 5.4% above its estimated fair value. The current Interest Coverage is 3.48, which is 98% below median its 10-year median of 216.76 and 72.7% below the Drug Manufacturers industry median of 12.77. Ono Pharmaceutical Co's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Ono Pharmaceutical Co (MEX:4528N), the current Interest Coverage is 3.48 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ono Pharmaceutical Co (MEX:4528N) Overvalued in 2026?
Based on GuruFocus' analysis, Ono Pharmaceutical Co stock appears to be overvalued.
The current stock price of MXN341.69 is trading 5.4% above its estimated GF Value™ of MXN324.16.
Key valuation signals for MEX:4528N:
Interest Coverage: 3.48 (98% below median its 10-year median of 216.76)
GF Value™: MXN324.16 vs. price of MXN341.69 (5.4% above fair value)
Industry Position: 72.7% below the Drug Manufacturers median (#255 of 684)
No single metric tells the full story. See the MEX:4528N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. The vast majority of the company's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of the company's sales is generated in Japan, followed by the rest of Asia and Europe.
88GF Score
Get the complete analysis for MEX:4528N
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:4528N has been successfully added to your 
